Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand

FEBS Letters

Volumn 447, Issue 1, 1999, Pages 61-64

  Monks, Lara K ^a   Cosgrove, Karen E ^b   Dunne, Mark J ^b   Ramsden, Christopher A ^a   G Morgan, Noel ^a   Chan, Sue L F ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

ATP sensitive potassium channel; Efaroxan; I site; Imidazoline; Insulin secretion

Indexed keywords

5 AMINOEFAROXAN; BINDING PROTEIN; EFAROXAN; IMIDAZOLINE DERIVATIVE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; RAT; TECHNIQUE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZOFURANS; BRAIN CHEMISTRY; CHROMATOGRAPHY, AFFINITY; HUMANS; IMIDAZOLES; INSULIN; ISLETS OF LANGERHANS; LIGANDS; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN BINDING; RATS; RECEPTORS, DRUG;

EID: 0032973340     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00264-1     Document Type: Article

References (41)

1. Bousquet P. J. Cardiovasc. Pharmacol. 26:1995;S1-S6.
2. Molderings G.J. Drugs Future. 22:1997;757-772.
3. Parini A., Moudanos C.G., Pizzinat N., Lanier S.M. Trends Pharmacol. Sci. 17:1996;13-16.
4. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., Dillon M.P. Trends Pharmacol. Sci. 19:1998;381-390.
5. French N. Pharmacol. Ther. 68:1995;175-208.
6. Escriba P.V., Ozaita A., Miralles A., Reis D.J., Garcia-Sevilla J.A. Mol. Brain Res. 32:1995;187-196.
7. Greney H., Bennai F., Molines A., Belcourt A., Dontenwill M., Bousquet P. Eur. J. Pharmacol. 265:1994;R1-R2.
8. Lione L.A., Nutt D.J., Hudson A.L. Eur. J. Pharmacol. 353:1998;123-135.
9. Ernsberger P.R., Graves M.E., Graff L.M., Zakieh N., Nguyen P., Collins L.A., Westbrooks K.L., Johnson G.G. Ann. New York Acad. Sci. 763:1995;22-42.
10. Ugedo L., Pineda J., Ruiz-Ortega J.A., Martin-Ruiz R. Br. J. Pharmacol. 125:1998;1685-1694.
11. Gothert M., Molderings G.J. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;271-282.
12. Coupry I., Podevin R.A., Dausse J.P., Parini A. Biochem. Biophys. Res. Commun. 147:1987;1055-1060.
13. Evans R.G., Haynes J.M. Clin. Exp. Pharmacol. Physiol. 21:1994;649-658.
14. Allan D.R., Penner S.B., Smyth D.D. Br. J. Pharmacol. 108:1993;875.
15. Head G.A. Ann. New York Acad. Sci. 763:1995;531-540.
16. Piletz J.E., Andorn A.C., Unnerstall J.R., Halaris A. Biochem. Pharmacol. 42:1991;569-584.
17. Diamant S., Eldar-Geva T., Atlas D. Br. J. Pharmacol. 106:1992;101-108.
18. Schulz A., Hasselblatt A. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;637-643.
19. Chan S.L.F., Morgan N.G. Eur. J. Pharmacol. 176:1990;97-101.
20. Berdeu D., Gross R., Ribes G., Loubatieres-Mariani M.-M., Bertrand G. Eur. J. Pharmacol. 254:1994;119-125.
21. Rustenbeck I., Kopp M., Polzin C., Hasselblatt A. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;390-393.
22. Mourtada M., Smith S.A., Morgan N.G. Eur. J. Pharmacol. 350:1998;251-258.
23. Dunne M.J. Br. J. Pharmacol. 103:1991;1847-1850.
24. Plant T.D., Jonas J.-C., Henquin J.-C. Br. J. Pharmacol. 104:1991;385-390.
25. Jonas J.-C., Plant T.D., Henquin J.-C. Br. J. Pharmacol. 107:1992;8-14.
26. Proks P., Ashcroft F.M. Proc. Natl. Acad. Sci. USA. 94:1997;11716-11720.
27. Dunne M.J., Harding E., Jagger J., Squires P., Liang R., Kane C., London N.J.M., James R.F.L. Ann. New York Acad. Sci. 763:1995;243-262.
28. Morgan, N.G., Chan, S.L.F., Mourtada, M., Monks, L.M. and Ramsden, C.A. (1999) Ann. N.Y. Acad. Sci. (in press).
29. Babenko A.P., Aguilar-Bryan L., Bryan J. Ann. Rev. Physiol. 60:1998;667-687.
30. Clement J.P., Kunjilwar K., Gonzalez G., Schwanstecher M., Panten U., Aguilar-Bryan L., Bryan J. Neuron. 18:1997;827-838.
31. Aguilar-Bryan L., Clement J.P., Gonzalez G., Kunjilwar K., Babenko A., Bryan J. Physiol. Rev. 78:1998;227-245.
32. Ashcroft F.M., Gribble F.M. Trends Neurosci. 21:1998;288-294.
33. Inagaki N., Tsuura Y., Namba N., Masuda K., Gonoi T., Horie M., Seino Y., Mizuta M., Seino S. J. Biol. Chem. 270:1995;5691-5694.
34. Inagaki N., Gonoi T., Clement J.P., Namba N., Inazawa J., Gonzalez G., Aguilar-Bryan L., Seino S., Bryan J. Science. 270:1995;1166-1170.
35. Brown C.A., Chan S.L.F., Stillings M.R., Smith S.A., Morgan N.G. Br. J. Pharmacol. 110:1993;1017-1022.
36. Ernsberger P., Graves M.E., Graff L.M., Zakieh N., Nguyen P., Collins L.A., Westbrooks K.L., Johnson G.D. Ann. New York Acad. Sci. 763:1995;22-42.
37. Chan S.L.F., Pallet A.L., Clews J., Ramsden C.A., Chapman J.C., Kane C., Dunne M.J., Morgan N.G. Eur. J. Pharmacol. 355:1998;67-76.
38. Dunne M.J., Illot M.C., Peterson O.H. J. Membr. Biol. 99:1987;215-224.
39. Findlay I., Dunne M.J. Pflug. Arch. 407:1986;238-240.
40. Lacey R.J., Cable H.C., James R.F., London N.J.M., Scarpello J.H.B., Morgan N.G. J. Endocrinol. 138:1993;555-563.
41. Tyacke R.J., Nutt D.J., Chan S.L.F., Ramsden C.A., Morgan N.G., Hudson A.L. Br. J. Pharmacol. 122:1997;SS66.